Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

Governments around the globe are working feverishly on a vaccine for the coronavirus, which has resulted in data recently published by the New England Journal of Medicine revealing that the Moderna’s coronavirus vaccine produced a “robust” immune response, or neutralizing antibodies, in all 45...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.